New York – Paul Hastings LLP, a leading global law firm, announced today that it continues to expand its Life Sciences Consulting Group, which collaborates with the lawyers in the firm’s leading Life Sciences practice to offer clients a one-stop shop for their legal, compliance, and operational execution needs. Most recently, the firm has welcomed Laura Skinner as a Director, Tricia Glover and Elaina McEwan as Senior Managers, Sarah Appelbaum as a Manager, and Madison Danoff as a Consultant in the Life Sciences Consulting Group. All five additions are based out of the firm’s New York office.
“Our Life Sciences Consulting Group offers clients practical services and solutions, partnering with our lawyers to deliver added value and efficiency,” said Gary Giampetruzzi, global chair of the Life Sciences practice at Paul Hastings. “With the addition of life sciences professionals like Laura, Tricia, Elaina, Sarah, and Madison, we continue to deepen the expertise and capabilities with which we serve our clients.”
“We are excited to welcome this dynamic group to the firm,” said BJ D’Avella, Life Sciences Consulting Group Leader. “As key members of our growing team, they will join me in shaping our offerings to clients from across the life sciences industry, and in helping our clients navigate a complex and evolving compliance and enforcement environment. They’ll also be key contributors to the design and growth of the first true consulting start-up within an elite, international law firm.”
Ms. Skinner and Ms. McEwan, who has also served on the inside at two different pharmaceutical companies, come to Paul Hastings from Deloitte’s Life Sciences Advisory practice. Ms. Glover, a longtime, well-known industry insider, last served as Vice President and North American Compliance Officer for Teva Pharmaceuticals. Ms. Appelbaum joins from Acquis Consulting Group, and Ms. Danoff joins from Pfizer, where she was a member of the company’s internal Strategy & Consulting group.
With 25 years of experience largely serving the global life sciences and healthcare industries, Laura Skinner is a strategic, detail-oriented finance and operations executive with acknowledged expertise in leading sales and marketing compliance, financial management, operational consolidation, and process improvement engagements. She has a keen understanding of the challenges facing clients’ organizations across the product lifecycle in operations, compliance, and technology, leading and building consensus across diverse cross-functional teams in developing compliance and operational frameworks. She specializes in fair market value assessments, compliance program development, risk management, ongoing operations, and healthcare professional engagement.
Tricia Glover has worked for and with various life sciences companies for over 35 years. She has a diverse background in areas related to manufacturing, sales, marketing, patient services, medical affairs, clinical operations, and global corporate compliance. Ms. Glover served in a Chief Compliance Officer role for 15 years and has a proven track record of strategically designing, enhancing and implementing effective compliance programs based on business risk and organizational design. She has experience interacting with the U.S. Department of Justice, Food and Drug Administration, and Federal Bureau of Investigation on compliance-related matters.
Elaina McEwan has over 12 years of life sciences industry experience assisting companies in mitigating evolving risk areas and maintaining compliance with industry regulations. She supports corporate compliance, legal counsel, and senior operations professionals on matters related to compliance program effectiveness, patient services compliance, sales and marketing compliance, government investigations, and medical/clinical operations. In addition to her consulting experience, Elaina has also held in-house roles in sales and compliance for two global pharmaceutical companies.
Sarah Appelbaum has wide-ranging experience helping multinational pharmaceutical corporations implement strategic operating model enhancements and specialty projects. Her life sciences experience spans medical affairs, commercial, finance, and corporate affairs. She has executed a number of high-impact initiatives beginning with the strategic ideation phase, guiding clients through implementation to deliver value across the organization.
Madison Danoff previously served in the Strategy & Consulting group at Pfizer, where she focused on high-level, high-impact strategic projects spanning early stage discovery, drug development, pre-launch commercial development, and commercialization. She has deep analytical experience in forecasting, pipeline prioritization, and clinical trial planning.
Paul Hastings’ interdisciplinary Life Sciences and Healthcare practice helps clients protect and enhance their value. The practice has partnered with more than half of the top 50 global life sciences companies on compliance program assessments and enhancements, high-stakes litigation, multi-faceted government compliance, investigations and enforcement issues, and complex cross-border transactions.
At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.